Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation

Clinical Biochemistry

Volumn 40, Issue 9-10, 2007, Pages 651-655

  Yagmur, E ^a   Trautwein, C ^b   Leers, M P G ^c   Gressner, A M ^a   Tacke, F ^b  

^a Institute of Clinical Chemistry and Pathobiochemistry   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c Sittard Geleen Heerlen   (Netherlands)

Author keywords

Apoptosis; Chronic liver disease; Cytokeratin 18; Liver cirrhosis; M30 antigen

Indexed keywords

ANTIGEN; BIOCHEMICAL MARKER; CASPASE; CYTOKERATIN 18; M30 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY M30; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIGEN DETECTION; APOPTOSIS; ARTICLE; BILIARY TRACT INFLAMMATION; CHOLANGITIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; INTRAHEPATIC CHOLESTASIS; LIVER BIOPSY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; APOPTOSIS; CHOLANGITIS; CHOLESTASIS, INTRAHEPATIC; CHRONIC DISEASE; KERATIN-18; LIVER DISEASES;

EID: 34249750909     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.12.010     Document Type: Article

References (16)

1. Omary M.B., Ku N.O., and Toivola D.M. Keratins: guardians of the liver. Hepatology 35 (2002) 251-257
2. Leers M.P., Kölgen W., Björklund V., et al. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J. Pathol. 187 (1999) 567-572
3. Ueno T., Toi M., Bivén K., Bando H., Ogawa T., and Linder S. Measurements of an apoptosis product in sera of breast cancer patients. Eur. J. Cancer 39 (2003) 769-774
4. Bantel H., Lügering A., Poremba C., et al. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology 34 (2001) 758-767
5. Bantel H., Lügering A., Heidemann J., et al. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology 40 (2004) 1078-1087
6. Yagmur E., Tacke F., Weiss C., et al. Elevation of Nepsilon-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis. Clin. Biochem. 39 (2006) 39-45
7. Pugh R.N., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., and Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 60 (1973) 646-649
8. Tacke F., Wustefeld T., Horn R., et al. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo. J. Hepatol. 42 (2005) 666-673
9. Ueno T., Toi M., and Linder S. Detection of epithelial cell death in the body by cytokeratin 18 measurement. Biomed. Pharmacother. 59 Suppl. 2 (2005 (Oct.)) S359-S362
10. Owens D.W., and Lane E.B. The quest for the function of simple epithelial keratins. BioEssays 25 (2003) 748-758
11. Seidel N., Volkmann X., Länge F., et al. The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum. Hepatology 42 (2005) 113-120
12. Kronenberger B., Wagner M., Herrmann E., et al. Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C. J. Viral. Hepat. 12 (2005) 307-314
13. Bantel H., Ruck P., Gregor M., and Schulze Osthoff K. Detection of elevated caspase activation and early apoptosis in liver diseases. Eur. J. Cell Biol. 80 (2001) 230-239
14. Guicciardi M.E., and Gores G.J. Apoptosis: a mechanism of acute and chronic liver injury. Gut 54 (2005) 1024-1033
15. Gehring S., Dickson E.M., San Martin M.E., et al. Kupffer cells abrogate cholestatic liver injury in mice. Gastroenterology 130 (2006) 810-822
16. Pinzani M. Non-invasive evaluation of hepatic fibrosis: don't count your chickens before they're hatched. Gut 55 (2006) 310-312